{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:33:43Z","timestamp":1790764423750,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10147-020-01623-y","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T13:02:41Z","timestamp":1579525361000},"page":"955-962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study"],"prefix":"10.1007","volume":"25","author":[{"given":"Ayumi","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1279-4971","authenticated-orcid":false,"given":"Akiko","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Shimizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konan","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kashiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Kino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Yasugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"1623_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7\u201330. https:\/\/doi.org\/10.3322\/caac.21442","journal-title":"CA Cancer J Clin"},{"key":"1623_CR2","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins EB et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144\u20131153","journal-title":"N Engl J Med"},{"key":"1623_CR3","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","volume":"340","author":"M Morris","year":"1999","unstructured":"Morris M, Eifel PJ, Lu J et al (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137\u20131143","journal-title":"N Engl J Med"},{"key":"1623_CR4","unstructured":"National Cancer Center National database of hospital-based cancer registries: 5\u00a0year survival report 2008\u20132009. National Cancer Center, Tokyo. https:\/\/ganjoho.jp\/data\/reg_stat\/statistics\/brochure\/hosp_c_reg_surv_all_2008-2009.pdf. Accessed Feb 2019"},{"key":"1623_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djs629","volume":"105","author":"SC Formenti","year":"2013","unstructured":"Formenti SC, Demaria S (2013) Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 105:256\u2013265. https:\/\/doi.org\/10.1093\/jnci\/djs629","journal-title":"J Natl Cancer Inst"},{"key":"1623_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fimmu.2018.00101eCollection","volume":"9","author":"SI Tsukumo","year":"2018","unstructured":"Tsukumo SI, Yasutomo K (2018) Regulation of CD8+ T cells and antitumor immunity by Notch signaling. Front Immunol 9:101. https:\/\/doi.org\/10.3389\/fimmu.2018.00101eCollection","journal-title":"Front Immunol"},{"key":"1623_CR7","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-04-0054","volume":"10","author":"I Kuss","year":"2004","unstructured":"Kuss I, Hathaway B, Ferris RL et al (2004) Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 10:3755\u20133762","journal-title":"Clin Cancer Res"},{"key":"1623_CR8","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-11-0774","volume":"17","author":"SA Grossman","year":"2011","unstructured":"Grossman SA, Ye X, Lesser G et al (2011) NABTT CNS consortium. immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res 17:5473\u20135480. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0774","journal-title":"Clin Cancer Res"},{"key":"1623_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11060-015-2037-1","volume":"127","author":"JS Mendez","year":"2016","unstructured":"Mendez JS, Govindan A, Leong J et al (2016) Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma. J Neurooncol 127:329\u2013335. https:\/\/doi.org\/10.1007\/s11060-015-2037-1","journal-title":"J Neurooncol"},{"key":"1623_CR10","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","volume":"89","author":"C Tang","year":"2014","unstructured":"Tang C, Liao Z, Gomez D et al (2014) Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes. Int J Radiat Oncol Biol Phys 89:1084\u20131091. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.04.025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1623_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s13277-015-3888-y","volume":"37","author":"O Cho","year":"2016","unstructured":"Cho O, Oh YT, Chun M et al (2016) Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer. Tumour Biol 37:971\u2013978. https:\/\/doi.org\/10.1007\/s13277-015-3888-y","journal-title":"Tumour Biol"},{"key":"1623_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.radonc.2018.02.025","volume":"128","author":"P Fang","year":"2018","unstructured":"Fang P, Jiang W, Davuluri R et al (2018) High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer. Radiother Oncol 128:584\u2013590. https:\/\/doi.org\/10.1016\/j.radonc.2018.02.025","journal-title":"Radiother Oncol"},{"key":"1623_CR13","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/hed.23535","volume":"36","author":"JL Campian","year":"2014","unstructured":"Campian JL, Sarai G, Ye X et al (2014) Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer. Head Neck 36:1747\u20131753. https:\/\/doi.org\/10.1002\/hed.23535","journal-title":"Head Neck"},{"key":"1623_CR14","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.1158\/1078-0432.CCR-14-1138","volume":"20","author":"P Kuo","year":"2014","unstructured":"Kuo P, Bratman SV, Shultz DB et al (2014) Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response. Clin Cancer Res 20:5558\u20135569. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-1138","journal-title":"Clin Cancer Res"},{"key":"1623_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/COC.0b013e3182940ff9","volume":"38","author":"AT Wild","year":"2015","unstructured":"Wild AT, Ye X, Ellsworth SG et al (2015) The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma. Am J Clin Oncol 38:259\u2013265. https:\/\/doi.org\/10.1097\/COC.0b013e3182940ff9","journal-title":"Am J Clin Oncol"},{"key":"1623_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","volume":"123","author":"BP Venkatesulu","year":"2018","unstructured":"Venkatesulu BP, Mallick S, Lin SH et al (2018) A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors. Crit Rev Oncol Hematol 123:42\u201351. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.01.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"1623_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ygyno.2015.11.013","volume":"140","author":"ES Wu","year":"2016","unstructured":"Wu ES, Oduyebo T, Cobb LP et al (2016) Lymphopenia and its association with survival in patients with locally advanced cervical cancer. Gynecol Oncol 140:76\u201382. https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.013","journal-title":"Gynecol Oncol"},{"key":"1623_CR18","doi-asserted-by":"publisher","first-page":"101042831773314","DOI":"10.1177\/1010428317734303","volume":"39","author":"O Cho","year":"2017","unstructured":"Cho O, Chun M, Oh YT et al (2017) Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma. Tumour Biol 39:1010428317733144. https:\/\/doi.org\/10.1177\/1010428317734303","journal-title":"Tumour Biol"},{"key":"1623_CR19","first-page":"3541","volume":"36","author":"O Cho","year":"2016","unstructured":"Cho O, Chun M, Chang SJ et al (2016) Prognostic value of severe lymphopenia during pelvic concurrent chemoradiotherapy in cervical cancer. Anticancer Res 36:3541\u20133547","journal-title":"Anticancer Res"},{"key":"1623_CR20","doi-asserted-by":"publisher","first-page":"4280436","DOI":"10.1007\/s10147-018-1374-4","volume":"24","author":"Y Yoshino","year":"2019","unstructured":"Yoshino Y, Taguchi A, Takao M et al (2019) Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer. Int J Clin Oncol 24:4280436. https:\/\/doi.org\/10.1007\/s10147-018-1374-4","journal-title":"Int J Clin Oncol"},{"key":"1623_CR21","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","volume":"69","author":"I Ray-Coquard","year":"2009","unstructured":"Ray-Coquard I, Cropet C, Van Glabbeke M et al (2009) European organization for research and treatment of cancer soft tissue and bone sarcoma group. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69:5383\u20135391. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3845","journal-title":"Cancer Res"},{"key":"1623_CR22","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00280-011-1610-3","volume":"68","author":"N C\u00e9z\u00e9","year":"2011","unstructured":"C\u00e9z\u00e9 N, Thibault G, Goujon G et al (2011) Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy. Cancer Chemother Pharmacol 68:1305\u20131313. https:\/\/doi.org\/10.1007\/s00280-011-1610-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"1623_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.lungcan.2011.06.009","volume":"75","author":"N Kobayashi","year":"2012","unstructured":"Kobayashi N, Usui S, Kikuchi S et al (2012) Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer 75:223\u2013227. https:\/\/doi.org\/10.1016\/j.lungcan.2011.06.009","journal-title":"Lung Cancer"},{"key":"1623_CR24","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1097\/MD.0000000000000257","volume":"93","author":"JF Feng","year":"2014","unstructured":"Feng JF, Liu JS, Huang Y (2014) Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma. Medicine (Baltimore) 93:e257. https:\/\/doi.org\/10.1097\/MD.0000000000000257","journal-title":"Medicine (Baltimore)"},{"key":"1623_CR25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/cam4.638","volume":"5","author":"F Kou","year":"2016","unstructured":"Kou F, Lu Z, Li J et al (2016) Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first-line chemotherapy. Cancer Med 5:778\u2013786. https:\/\/doi.org\/10.1002\/cam4.638","journal-title":"Cancer Med"},{"key":"1623_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/annonc\/mdv546","volume":"27","author":"N Joseph","year":"2016","unstructured":"Joseph N, Dovedi SJ, Thompson C et al (2016) Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer. Ann Oncol 27:294\u2013299. https:\/\/doi.org\/10.1093\/annonc\/mdv546","journal-title":"Ann Oncol"},{"key":"1623_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10060194","author":"A Dahmani","year":"2018","unstructured":"Dahmani A, Delisle JS (2018) TGF-\u03b2 in T cell biology: implications for cancer immunotherapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers10060194","journal-title":"Cancers (Basel)"},{"key":"1623_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri704","volume":"2","author":"L Gorelik","year":"2002","unstructured":"Gorelik L, Flavell RA (2002) Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2:46\u201353","journal-title":"Nat Rev Immunol"},{"key":"1623_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/cas.13433","volume":"109","author":"H Tsukamoto","year":"2018","unstructured":"Tsukamoto H, Fujieda K, Senju S et al (2018) Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity. Cancer Sci 109:523\u2013530. https:\/\/doi.org\/10.1111\/cas.13433","journal-title":"Cancer Sci"},{"key":"1623_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2307\/3577549","volume":"123","author":"N Nakamura","year":"1990","unstructured":"Nakamura N, Kusunoki Y, Akiyama M (1990) Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay. Radiat Res 123:224\u2013227","journal-title":"Radiat Res"},{"key":"1623_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/07357907.2012.762780","volume":"31","author":"S Yovino","year":"2013","unstructured":"Yovino S, Kleinberg L, Grossman SA et al (2013) The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Invest 31:140\u2013144. https:\/\/doi.org\/10.3109\/07357907.2012.762780","journal-title":"Cancer Invest"},{"key":"1623_CR32","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/1097-0142(197603)37:3<1417::AID-CNCR2820370324>3.0.CO;2-N","volume":"37","author":"M Raben","year":"1976","unstructured":"Raben M, Walach N, Galili U et al (1976) The effect of radiation therapy on lymphocyte subpopulations in cancer patients. Cancer 37:1417\u20131421","journal-title":"Cancer"},{"key":"1623_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.radonc.2015.11.020","volume":"118","author":"C Sini","year":"2016","unstructured":"Sini C, Fiorino C, Perna L et al (2016) Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation. Radiother Oncol 118:79\u201384. https:\/\/doi.org\/10.1016\/j.radonc.2015.11.020","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-020-01623-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:33:55Z","timestamp":1611016435000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-020-01623-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1623"],"URL":"https:\/\/doi.org\/10.1007\/s10147-020-01623-y","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,20]]},"assertion":[{"value":"25 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study protocol was approved by our internal Institutional Review Board of Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital (Approval number: 1948).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}